Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
It is a signaling peptide
Common adverse reactions included nausea, diarrhea, and vomiting.172 GSBR-1290 GSBR-1290 is an oral small molecule GLP-1RA developed by Structure Therapeutics, aimed at treating T2DM and obesity
Rather than focusing solely on weight loss, the program is meant to address early metabolic risk factors linked to chronic disease and support longevity, and is open to individuals with a BMI of 21 or higher
Dedicado inovao, pesquisa e aprimoramento, ele opera com o mais alto rigor cientfico
Consume one tablet once daily, or as directed by a healthcare professional.
(US), Amgen Inc
US$ 20.51
US$ 21.34
US$ 22.35
